Antibody persistence and evidence of immune memory at 5years following administration of the 9-valent HPV vaccine.
about
Efficacy, immunogenicity, and safety of a 9-valent human papillomavirus vaccine in Latin American girls, boys, and young women.Immunogenicity of HPV prophylactic vaccines: Serology assays and their use in HPV vaccine evaluation and development.Safety profile of the 9-valent human papillomavirus vaccine: assessment in prior quadrivalent HPV vaccine recipients and in men 16 to 26 years of age.9-Valent human papillomavirus vaccine: a review of the clinical development program.
P2860
Antibody persistence and evidence of immune memory at 5years following administration of the 9-valent HPV vaccine.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Antibody persistence and evide ...... n of the 9-valent HPV vaccine.
@en
type
label
Antibody persistence and evide ...... n of the 9-valent HPV vaccine.
@en
prefLabel
Antibody persistence and evide ...... n of the 9-valent HPV vaccine.
@en
P2093
P1433
P1476
Antibody persistence and evide ...... on of the 9-valent HPV vaccine
@en
P2093
Alain Luxembourg
Amita Joshi
Ana Guevara
Christine Shields
Elmar Joura
Linn Woelber
Misoo C Ellison
Olaf Reich
Robinson Cabello
P304
P356
10.1016/J.VACCINE.2017.07.017
P407
P577
2017-08-05T00:00:00Z